Pages that link to "Q34576112"
Jump to navigation
Jump to search
The following pages link to Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria (Q34576112):
Displaying 50 items.
- Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein (Q24293224) (← links)
- Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells (Q24541460) (← links)
- Thrombosis in paroxysmal nocturnal hemoglobinuria (Q26853483) (← links)
- Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55) (Q28187043) (← links)
- Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene (Q28188310) (← links)
- Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (Q28256613) (← links)
- The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility (Q28256629) (← links)
- Binding of human and rat CD59 to the terminal complement complexes (Q28565870) (← links)
- Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium (Q28568260) (← links)
- Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement (Q28569128) (← links)
- Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site (Q28572539) (← links)
- Infectious diseases associated with complement deficiencies (Q30450183) (← links)
- Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship (Q30877909) (← links)
- Diagnostic surface expression of SWAP-70 on HIV-1 infected T cells (Q33237009) (← links)
- Leukemia arising out of paroxysmal nocturnal hemoglobinuria (Q33536877) (← links)
- Clonal evolution of aplastic anaemia to myelodysplasia/acute myeloid leukaemia and paroxysmal nocturnal haemoglobinuria (Q33604344) (← links)
- A recombination event in the 5' flanking region of the Ly-6C gene correlates with impaired expression in the NOD, NZB and ST strains of mice (Q33924154) (← links)
- The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury (Q33990334) (← links)
- Historical aspects of paroxysmal nocturnal haemoglobinuria: 'defining the disease'. (Q34120817) (← links)
- Control of the complement system. (Q34400002) (← links)
- Hemoglobinuria misidentified as hematuria: review of discolored urine and paroxysmal nocturnal hemoglobinuria (Q34462881) (← links)
- Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria (Q34578218) (← links)
- Targeting therapy to the neuromuscular junction: proof of concept. (Q34974981) (← links)
- Cell surface complement regulators moderate experimental myasthenia gravis pathology (Q35021497) (← links)
- Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention (Q35236103) (← links)
- Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscape (Q35252156) (← links)
- A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria (Q35670980) (← links)
- Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59 (Q35763321) (← links)
- Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement (Q35766363) (← links)
- Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase (Q35816948) (← links)
- Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria (Q35992349) (← links)
- Development of complement therapeutics for inhibition of immune-mediated red cell destruction (Q36222203) (← links)
- Sequence-specific 1H-NMR assignments and folding topology of human CD59. (Q36277854) (← links)
- New Insights on Complement Inhibitor CD59 in Mouse Laser-Induced Choroidal Neovascularization: Mislocalization After Injury and Targeted Delivery for Protein Replacement (Q36319522) (← links)
- Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 (Q36365174) (← links)
- Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia (Q36416292) (← links)
- Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients. (Q36563619) (← links)
- Restriction factors of homologous complement: A new candidate? (Q36572435) (← links)
- Paroxysmal nocturnal hemoglobinuria and glycosyl phosphatidylinositol anchored proteins that regulate complement (Q36691261) (← links)
- The control of homologous lysis (Q36705635) (← links)
- Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis (Q36803615) (← links)
- Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment? (Q36858180) (← links)
- Rational engineering of a minimized immune inhibitor with unique triple-targeting properties (Q37300691) (← links)
- Assembly and deacetylation of N-acetylglucosaminyl-plasmanylinositol in normal and affected paroxysmal nocturnal hemoglobinuria cells (Q37496518) (← links)
- Anti-Complement Treatment in Paroxysmal Nocturnal Hemoglobinuria: Where we Stand and Where we are Going (Q37724607) (← links)
- Laboratory tests for paroxysmal nocturnal hemoglobinuria (Q38152731) (← links)
- Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition (Q38156229) (← links)
- Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations (Q38261555) (← links)
- Update on the diagnosis and management of paroxysmal nocturnal hemoglobinuria. (Q39027745) (← links)
- Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection (Q39740020) (← links)